Abiopharma

FDA approve OLANZAPINE

FDA approve DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

FDA approve ZIPRASIDONE MESYLATE

FDA approve FLUOCINOLONE ACETONIDE

FDA approve SELEGILINE HYDROCHLORIDE

NASDAQ symbol attribute type Security_Name was changed. Previous value: -. New value: Star Equity Holdings, Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: -. New value: N.

NASDAQ symbol attribute type Test_mode was changed. Previous value: -. New value: N.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: -. New value: N.

NASDAQ symbol attribute type Security_Name was changed. Previous value: -. New value: Star Equity Holdings, Inc. - 10% Series A Cumulative Perpetual Preferred Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: -. New value: N.

Novo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress

Sampo Oyj:n omien osakkeiden ostot 4.9.2025

Sampo plc’s share buybacks 4 September 2025

VIEL & Cie : CROISSANCE DES RESULTATS AU S1 2025 Chiffre d’affaires consolidé + 9,4%* Résultat d’exploitation +15,6%* (y compris sociétés associées) Résultat net +7,5%* Résultat net pdg +5,7%